Designed to curb addiction, US approves first non-opioid painkiller in over 25 years
The US Food and Drug Administration has approved a new pain reliever named suzetrigine, marking the first approval of a new type of pain medication in over 25 years. This drug is designed to reduce addiction and overdose risks and will be sold under the brand name Journavx.
The US Food and Drug Administration has approved a new pain reliever named suzetrigine, marking the first approval of a new type of pain medication in over 25 years. This drug is designed to reduce addiction and overdose risks and will be sold under the brand name Journavx.
